According to LENZ Therapeutics's latest financial reports the company has C$0.31 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | C$60.3 M | 158.47% |
2021-12-31 | C$23.33 M |